- Largazole is a Brain-Penetrant Class I HDAC Inhibitor with Extended Applicability to Glioblastoma and CNS Diseases
Fatma H. Al-Awadhi et al, 2020, ACS Chem. Neurosci. CrossRef - Epigenetics: Recent Advances and Its Role in the Treatment of Alzheimer's Disease
Xuewen Xiao et al, 2020, Front. Neurol. CrossRef - null
Mohammed Noorladeen Al–Qattan et al, 2020 CrossRef - A Glycolysis Gene Methylation Prediction Model Based on Explainable Machine Learning for Alzheimer's Disease
Fang Wang et al, 2021, SSRN Journal CrossRef - Diet, Sports, and Psychological Stress as Modulators of Breast Cancer Risk: Focus on OPRM1 Methylation
Liangliang Li et al, 2021, Front. Nutr. CrossRef - DNA Methylation: A Promising Approach in Management of Alzheimer’s Disease and Other Neurodegenerative Disorders
Gagandeep Kaur et al, 2022, Biology CrossRef - Increased pain unpleasantness and pain-related fMRI activation in the periaqueductal gray in Alzheimer's disease
Alison R. Anderson et al, 2022, Front. Pain Res. CrossRef - The role of opioid receptors in modulating Alzheimer’s Disease
Parthasaradhireddy Tanguturi et al, 2023, Front. Pharmacol. CrossRef - ADmeth: A Manually Curated Database for the Differential Methylation in Alzheimer's Disease
Xiaoqing Peng et al, 2023, IEEE/ACM Trans. Comput. Biol. and Bioinf. CrossRef